This inventor holds 2 USPTO granted patents. Top assignee: Ciba-Geigy Corporation. Active years: 1977-1987.
Company Filing History:
Years Active: 1977-1987
Title: Alex Meisels: Innovator in Pharmaceutical Compounds
Introduction
Alex Meisels is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds that exhibit valuable pharmacological properties. With a total of 2 patents, Meisels continues to push the boundaries of medical science.
Latest Patents
Meisels' latest patents include groundbreaking work on derivatives of 2,4-thiazolidinedione. These compounds are characterized by their substitution in the 3-positions and 5-positions, which enhances their effectiveness in inhibiting tumor growth while maintaining low toxicity levels. Another significant patent involves heterocyclic spiro compounds, which demonstrate antiviral activity and serve as active ingredients in pharmaceutical compositions.
Career Highlights
Throughout his career, Alex Meisels has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. His work has led to the development of compounds that not only have therapeutic potential but also contribute to advancements in drug formulation and efficacy.
Collaborations
Meisels has collaborated with esteemed colleagues such as Angelo Storni and Karl Schaffner. These partnerships have fostered an environment of innovation and have been instrumental in the successful development of his patented compounds.
Conclusion
Alex Meisels stands out as a significant figure in the realm of pharmaceutical innovation. His contributions through his patents reflect a commitment to improving health outcomes and advancing medical science.